federal_register: 2014-28888

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2014-28888 Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products-Content and Format; Guidance for Industry; Availability Notice The Food and Drug Administration (FDA or the Agency) is announcing the availability of a guidance for industry entitled "Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products--Content and Format." The recommendations in this guidance are intended to assist applicants in developing the "Patient Counseling Information" section of labeling and to help ensure that this section of labeling is clear, useful, informative, and to the extent possible, consistent in content and format. This guidance finalizes the draft guidance issued on September 18, 2013. 2014-12-10 2014 12 https://www.federalregister.gov/documents/2014/12/10/2014-28888/patient-counseling-information-section-of-labeling-for-human-prescription-drug-and-biological https://www.govinfo.gov/content/pkg/FR-2014-12-10/pdf/2014-28888.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or the Agency) is announcing the availability of a guidance for industry entitled "Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products--Content and Format." The...

Links from other tables